The CPA3+ cell count showed a significant increase in the total number of MCs in COVID-19 patients compared with the control group in pneumonic (Figure 3f), thrombotic (Figure 3g), and fibrotic areas (Figure 3h) areas. Here, CPA3 is linked to COVID-19.